Chronic prostatitis and biofilm;Prostatiti croniche e biofilm

Infezioni in Medicina

Volumn 17, Issue SUPPL. 1, 2009, Pages 10-16

  Bartoletti, Riccardo ^a   Cai, Tommaso ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Biofilm; Meares Stamey test; Prostatitis; UTI

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN;

BIOFILM; CHRONIC PROSTATITIS; GROUPS BY AGE; HUMAN; MICROBIOLOGICAL EXAMINATION; PLANKTON; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHRONIC DISEASE; DIET; DISEASE PREDISPOSITION; DRUG EFFECT; ITALY; MALE; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; PROSTATITIS; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STATISTICS; URINARY TRACT INFECTION; VIROLOGY;

ADULT; BIOFILMS; CHRONIC DISEASE; CIPROFLOXACIN; CONTRACEPTION BEHAVIOR; DIET; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, MICROBIAL; HUMANS; ITALY; MALE; MIDDLE AGED; OFLOXACIN; PROSPECTIVE STUDIES; PROSTATITIS; RISK FACTORS; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SEXUALLY TRANSMITTED DISEASES, VIRAL; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 70350469115     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Naber K.G., Lobel B., Weidner W. et al. Further insights into endocrine disease. The enigma of prostatits. An IPHC teaching Programme.
2. Bartoletti R., Cai T., Mondaini N., et al. and the Italian Prostatitis Study Group. Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study. J Urol. 178 (6), 2411-2415, 2007.
3. Mehik A., Hellström P., Lukkarinen O., Sarpola A., Järvelin M. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int. 86 (4), 443-448, 2000.
4. Macfarlane S. Microbial biofilm communities in the gastrointestinal tract J. Clin. Gastroenterol. 42 (Suppl. 3), S142-S143, 2008.
5. Korrowits P., Ausmess K., Mandar R., Punab M. Prevalence of asymptomatic inflammatory (National Institutes of Health category IV) prostatitis in young men according to semen analysis. Urology 71 (6), 1010-1015, 2008.
6. Soto S.M., Smithson A., Martinez J.A., Horcajada J.P., Mensa J., Vila J. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J. Urol. 177 (1), 365-368, 2007.
7. Goto T., Nakame Y., Nishida M., Ohi Y., In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine. Urology 53, 1058-1062, 1999. (Pubitemid 29196329)
8. Drusano G.L., Preston S.L., Van Guilder M., et al. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob. Agents Chemother. 44 (8), 2046-2051, 2000.
9. Lugg J., Lettieri J., Stass H., Agarwal V. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose. J. Chemother. 20 (2), 213-218, 2008. (Pubitemid 351797062)
10. Waldron R., Arkell D.G., Wise R., Andrews J.M. The intraprostatic penetration of ciprofloxacin. J. Antimicrob. Chemother. 17 (4), 544-545, 1986.